Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
1989
DOI: 10.1016/0014-2999(89)90233-1
|View full text |Cite
|
Sign up to set email alerts
|

Receptor binding of fluorinated histidine analogs of thyrotropin-releasing hormone in various regions of the rat brain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

1990
1990
2015
2015

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 19 publications
(3 citation statements)
references
References 28 publications
0
3
0
Order By: Relevance
“…TRH has multiple biological effects at various anatomical sites which may be mediated via different TRH receptor subtypes (22)(23)(24)(25). Previously, we have observed that backbone thionation of enkephalins yielded receptor-selective analogs (12,15).…”
Section: Resultsmentioning
confidence: 99%
“…TRH has multiple biological effects at various anatomical sites which may be mediated via different TRH receptor subtypes (22)(23)(24)(25). Previously, we have observed that backbone thionation of enkephalins yielded receptor-selective analogs (12,15).…”
Section: Resultsmentioning
confidence: 99%
“…[20][21][22][23] The molecular docking analysis reveals a second binding site of TRH-DE, which is surrounded by Tyr527, Phe522, Pro269, Phe956, Met406, Tyr403, Gln266, Ser268, Met957, Pro402, Ala239, Ile241, Arg950, Ile236, Thr949, Asn238, Tyr237, Lys146, Glu953, Lys274, Gly952, His271, Leu955 and Asp519 amino acid residues (Fig. 15).…”
Section: Computational Studies Of Peptide 8c With Trh-dementioning
confidence: 98%
“…The synthesized analogs bind to TRH-R2 with slightly higher affinity than TRH-R1 and displayed selective activation for TRH-R2. 22,23 Simultaneous replacement of the central histidine in TRH by leucine or norvaline and the terminal amino acid pGlu by other heterocycles led to the identification of RGH-2202 (posatirelin), which is 5 times more CNS potent than TRH with weaker hormonal activity. Several studies involving this analog reported improved cognitive and functional abilities for late onset of Alzheimer's disease and RGH-2202 is currently in phase III clinical trial as a cognition enhancer.…”
Section: Introductionmentioning
confidence: 99%